ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Cleveland, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Non-Small-Cell Lung Carcinoma

Adenocarcinoma trials near Cleveland, OH, USA:

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma...

Enrolling
Advanced Adenocarcinoma
Drug: BA3182

Phase 1

BioAtla

Cleveland, Ohio, United States and 4 other locations

participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...

Enrolling
Endometrial Adenocarcinoma
Urothelial Carcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Cleveland, Ohio, United States and 67 other locations

first-line treatment of participants with locally advanced unresectable or metastatic gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...

Active, not recruiting
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Drug: Domvanalimab
Drug: Zimberelimab

Phase 3

Arcus Biosciences
Arcus Biosciences

Cleveland, Ohio, United States and 192 other locations

The goal of this clinical trial is to test an experimental treatment (immunotherapy) in pancreatic cancer patients. The main research objectives are:...

Enrolling
Pancreatic Ductal Adenocarcinoma
Drug: ATP150
Drug: Ezabenlimab

Phase 1

Amal Therapeutics

Cleveland, Ohio, United States and 14 other locations

after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponso...

Begins enrollment this month
Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Rilvegostomig

Phase 3

AstraZeneca
AstraZeneca

Cleveland, Ohio, United States and 138 other locations

as monotherapy (Part C) and in combination with first-line SoC treatment (Part D) in patients with advanced or metastatic pancreatic adenocarcinoma...

Enrolling
Pancreatic Cancer
Drug: SOT102

Phase 1, Phase 2

SOTIO
SOTIO

Cleveland, Ohio, United States and 7 other locations

This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody ta...

Enrolling
Colorectal Adenocarcinoma
Pancreatic Adenocarcinoma
Drug: 5-fluorouracil
Drug: Carboplatin

Phase 1

Inhibrx

Cleveland, Ohio, United States and 18 other locations

This trial studies tucatinib to find out if it is safe when given with trastuzumab and other anti-cancer drugs (pembrolizumab, FOLFOX, and CAPOX). It...

Active, not recruiting
Esophageal Adenocarcinoma
Gastric Adenocarcinoma
Drug: oxaliplatin
Drug: trastuzumab

Phase 1, Phase 2

Seagen
Seagen

Cleveland, Ohio, United States and 21 other locations

This is a first-in-human, open-label, multi-center, Phase 1, dose-escalation study with expansion cohorts to evaluate NM32-2668 for safety and immuno...

Enrolling
Adenocarcinoma - Gastroesophageal Junction (GEJ)
Adenocarcinoma of the Stomach
Biological: NM32-2668

Phase 1

Numab Therapeutics

Cleveland, Ohio, United States and 5 other locations

This study is open to adults with advanced cancer in the biliary tract, pancreas, lung, or bladder. This is a study for people for whom previous trea...

Enrolling
Lung Neoplasms
Bladder Cancer
Drug: brigimadlin

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Cleveland, Ohio, United States and 65 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems